HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1112094Generated: November 2, 2026
N-Desalkyl-3-hydroxyflurazepam → HCID 13125988, compound
https://huagongshe.com/reaction/1112094
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | N-Desalkyl-3-hydroxyflurazepam | HCID 28648 | — |
| Reactant | (Diethylamino)sulfur trifluoride | HCID 123472 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 13125988 | HCID 13125988 | 67% |
Reaction Steps
A well stirred suspension of 3.0 g (0.01 mole) of 3-hydroxy-1,3-dihydro-7-chloro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one in 150 ml of methylene chloride was cooled to -70°, and 7.5 ml (0.06 mol) of diethylaminosulfur trifluoride was added dropwise over a period of 10 min. The reaction mixture was then allowed to warm slowly over a period of 26 min. to -10° and then poured into 200 ml of ice water. The organic layer was separated, dried over MgSO4, and evaporated to dryness under reduced pressure to give 2.95 g (98%) of crude product. Recrystallization from benzene-heptane gave 2.00 g (67%) of 3-fluoro-1,3-dihydro-7-chloro-5-(2-fluorophenyl)-2H-1,4-benzodiazepin-2-one as off-white crystals: mp 206°-207° (dec); 1H nmr (DMSO-d6) δ 5.95 ppm (d, J = 56 Hz, 1H), 7.47 ppm (m, 7H), 11.25 ppm (s, 1H); 19F nmr (DMSO-d6) δ -162.0 ppm (d, J = 56 Hz, 1F) and δ -113.0 ppm (m, 1F).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US04120856 |
|---|
| Source dataset | uspto-grants-1978_10 |
|---|
| ORD ID | ord-c2349414d0bb44e58ddcd23b14fa5ac2 |
|---|
| Source note | uspto-grants-1978_10 |
|---|